{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:30:01Z","timestamp":1758990601637},"reference-count":12,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,3,20]],"date-time":"2002-03-20T00:00:00Z","timestamp":1016582400000},"content-version":"vor","delay-in-days":47,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Ophthalmologica Scandinavica"],"published-print":{"date-parts":[[2002,2]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title><jats:p><jats:bold>Purpose:\u2002<\/jats:bold> To describe the treatment of cytomegalovirus (CMV) retinitis with intravitreal sustain\u2010release ganciclovir devices in a 16\u2010year\u2010old patient in third remission of acute lymphoblastic leukemia after stem cell transplantation.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The patient received a stem cell transplant from an unrelated bone marrow donor after which he contracted a serious CMV infection manifested in the lungs and retinae. His immune system at this time was almost completely depleted. Implantation of a sustained\u2010release ganciclovir device was performed in both eyes when retinitis progressed in spite of aggressive antiviral intravenous treatment.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> No per\u2010 or postoperative complications were noted. Infiltrates, hemorrhages and macular edema present preoperatively dissolved over a period of six months. The final visual acuity was 1.0 in both eyes. The patients immune system and lung function slowly recovered during the same time period.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> The intravitreal ganciclovir implant provides safe and effective therapy against CMV retinitis, and should be considered in patients acquiring the infection after stem cell transplantation.<\/jats:p>","DOI":"10.1034\/j.1600-0420.2002.800121.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:18:44Z","timestamp":1047352724000},"page":"101-104","source":"Crossref","is-referenced-by-count":13,"title":["Intravitreal sustained\u2010release ganciclovir implants for severe bilateral cytomegalovirus retinitis after stem cell transplantation"],"prefix":"10.1111","volume":"80","author":[{"given":"Fredrik","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars\u2010J\u00f6rgen","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnel","family":"Bynke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert N.","family":"B\u00e9k\u00e1ssy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,3,20]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1993.01090020077027"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30677-5"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890230412"},{"key":"e_1_2_4_5_1","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs DA","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_2_4_6_1","first-page":"473","article-title":"Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: prevalence, natural history, and response to ganciclovir therapy","volume":"67","author":"Jacobson MA","year":"1988","journal-title":"Q J Med"},{"key":"e_1_2_4_7_1","first-page":"587","article-title":"Successful treatment of CMV retinitis with ganciclovir after allogeneic marrow transplantation","volume":"4","author":"Kaulfersch W","year":"1989","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1994.01090240037023"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)71090-6"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(95)31010-X"},{"key":"e_1_2_4_11_1","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel P","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1992.01080140044023"},{"key":"e_1_2_4_13_1","doi-asserted-by":"crossref","unstructured":"YoungS MorletN BesenG WileyCA JonesP GoldJ LiY FreemanWR&CoroneoMT(1998): High\u2010dose (2000 \u2013 microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis. Ophthalmology 105:1404\u20131410.","DOI":"10.1016\/S0161-6420(98)98020-4"}],"container-title":["Acta Ophthalmologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0420.2002.800121.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0420.2002.800121.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0420.2002.800121.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T21:13:42Z","timestamp":1697577222000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0420.2002.800121.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["10.1034\/j.1600-0420.2002.800121.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0420.2002.800121.x","archive":["Portico"],"relation":{},"ISSN":["1395-3907","1600-0420"],"issn-type":[{"value":"1395-3907","type":"print"},{"value":"1600-0420","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}